Russia's Sputnik V Vaccine Targets November Distribution

The chief of Russia's sovereign wealth fund, which is backing the new Sputnik V vaccine, said to CNBC on September 4, 2020, the country was “on track” to provide exports of the new coronavirus preventive vaccine by November 2020.

This positive announcement is related to the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation's publication of a scientific article in The Lancet on the results of Phase I-II clinical trials of the world's first registered coronavirus vaccine, Sputnik V.

“We are now witnessing a change in the global approach towards the registration of vaccines with the USA, UK, China, and other countries following Russia's path in fast-tracking registration," stated Kirill Dmitriev, CEO of the Russian Direct Investment Fund, in a related press statement.